Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome
about
Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and managementNew directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunityImmunosuppressive therapy for transplant-ineligible aplastic anemia patients.Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.Immunological derangement in hypocellular myelodysplastic syndromes.Recent developments in drug therapy for aplastic anemia.Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience.Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review.Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations.Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis.Long-term outcome of immunosuppressive therapy for Japanese patients with lower-risk myelodysplastic syndromes.Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management.
P2860
Q26796240-95F821A2-1B1F-412A-85E5-1057A0639993Q26823090-7994684F-80EE-4FEB-BEF6-64D085706953Q33419679-2E31BD1D-9832-415A-88D4-40F7805EA07FQ37676271-8ADC2D70-69D0-4679-AFDE-287BEE9B0B63Q37676274-C55324D8-AC93-47C6-A3A5-9D12361A11EAQ37724605-BFFA31FC-DA2C-412A-9488-FB7FA0A678B3Q38245750-01DC728B-4FFD-4C84-89FD-9F382B6D9C28Q38636146-CFF311FD-AF55-4CDB-B399-86238B730564Q39269167-4410BBBB-7477-4534-9ED1-83A7034EE6C0Q39659581-3F169833-7EAD-4F2D-931C-58F981105C86Q41489617-9FA71758-E8EF-457B-954C-DB1961A8931FQ45079106-9983B9CA-5B11-4FDF-B069-5AEEE6612398Q47548041-00E64E6C-17AB-4744-BFFD-F1B572730AE9
P2860
Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Final results of the phase II ...... a and myelodysplastic syndrome
@en
Final results of the phase II ...... and myelodysplastic syndrome.
@nl
type
label
Final results of the phase II ...... a and myelodysplastic syndrome
@en
Final results of the phase II ...... and myelodysplastic syndrome.
@nl
prefLabel
Final results of the phase II ...... a and myelodysplastic syndrome
@en
Final results of the phase II ...... and myelodysplastic syndrome.
@nl
P2093
P2860
P50
P1476
Final results of the phase II ...... a and myelodysplastic syndrome
@en
P2093
Charles Koller
Mark Brandt
Sergerrne York
Tapan M Kadia
Xuelin Huang
P2860
P304
P356
10.1111/J.1365-2141.2012.09064.X
P407
P50
P577
2012-02-24T00:00:00Z